Evaxion Biotech A/S (EVAX) Competitors

Evaxion Biotech A/S (NASDAQ:EVAX) and Dogwood Therapeutics (NASDAQ:DWTX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, community ranking, analyst recommendations and risk.

Which has more risk & volatility, EVAX or DWTX?

Evaxion Biotech A/S has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500. Comparatively, Dogwood Therapeutics has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in EVAX or DWTX?

11.0% of Evaxion Biotech A/S shares are held by institutional investors. Comparatively, 9.1% of Dogwood Therapeutics shares are held by institutional investors. 41.6% of Evaxion Biotech A/S shares are held by company insiders. Comparatively, 12.2% of Dogwood Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the media prefer EVAX or DWTX?

In the previous week, Evaxion Biotech A/S had 7 more articles in the media than Dogwood Therapeutics. MarketBeat recorded 9 mentions for Evaxion Biotech A/S and 2 mentions for Dogwood Therapeutics. Evaxion Biotech A/S's average media sentiment score of 0.22 beat Dogwood Therapeutics' score of -0.38 indicating that Evaxion Biotech A/S is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evaxion Biotech A/S	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dogwood Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in EVAX or DWTX?

Evaxion Biotech A/S received 26 more outperform votes than Dogwood Therapeutics when rated by MarketBeat users.

Company	Underperform	Outperform
Evaxion Biotech A/S	Outperform Votes 26 66.67%	Underperform Votes 13 33.33%
Dogwood Therapeutics	N/A	N/A

Which has preferable earnings and valuation, EVAX or DWTX?

Dogwood Therapeutics has lower revenue, but higher earnings than Evaxion Biotech A/S. Evaxion Biotech A/S is trading at a lower price-to-earnings ratio than Dogwood Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evaxion Biotech A/S	$3.30M	0.59	-$22.12M	-$1.45	-1.14
Dogwood Therapeutics	N/A	N/A	-$5.30M	-$11.34	-0.43

Do analysts prefer EVAX or DWTX?

Evaxion Biotech A/S currently has a consensus price target of $20.00, indicating a potential upside of 1,104.82%. Given Evaxion Biotech A/S's stronger consensus rating and higher possible upside, equities analysts plainly believe Evaxion Biotech A/S is more favorable than Dogwood Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evaxion Biotech A/S	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dogwood Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is EVAX or DWTX more profitable?

Dogwood Therapeutics has a net margin of 0.00% compared to Evaxion Biotech A/S's net margin of -347.83%. Evaxion Biotech A/S's return on equity of 0.00% beat Dogwood Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evaxion Biotech A/S	-347.83%	N/A	-79.40%
Dogwood Therapeutics	N/A	-217.12%	-172.06%

Summary

Evaxion Biotech A/S beats Dogwood Therapeutics on 12 of the 16 factors compared between the two stocks.